Clonal expansion is a characteristic feature of the B-cell repertoire of patients with rheumatoid arthritis
The present study was designed to analyze the level of B-cell clonal
diversity in patients with rheumatoid arthritis by using HCDR3 (third
complementarity determining region of the rearranged heavy chain variable
region gene) length as a marker. A modified immunoglobulin VH gene
fingerprinting method using either genomic DNA or complementary (c)DNA derived
from B cells of the peripheral blood, synovial fluid, and tissues of several
rheumatoid arthritis patients was employed. These assays permitted the
detection and distinction of numerically expanded B-cell clones from activated
but not numerically expanded B-cell clones. The present data suggest that
B-cell clonal expansion is a common and characteristic feature of rheumatoid
arthritis and that it occurs with increasing frequency from the blood to the
synovial compartments, resulting in a narrowing of the clonal repertoire at the
synovial level. These clonal expansions can involve resting, apparently memory
B cells, as well as activated B cells. Furthermore, some of these individual
expansions can persist over extended periods of time. These findings support
the hypothesis that a chronic ongoing (auto)immune reaction is operative in
rheumatoid arthritis and that this reaction, at least at the B-cell level, may
be unique to each individual joint. A determination of the targets of these
autoimmune reactions may provide valuable clues to help understand the
immunopathogenesis of this disease.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@nih.gov"
}
|
| description | The present study was designed to analyze the level of B-cell clonal diversity in patients with rheumatoid arthritis by using HCDR3 (third complementarity determining region of the rearranged heavy chain variable region gene) length as a marker. A modified immunoglobulin VH gene fingerprinting method using either genomic DNA or complementary (c)DNA derived from B cells of the peripheral blood, synovial fluid, and tissues of several rheumatoid arthritis patients was employed. These assays permitted the detection and distinction of numerically expanded B-cell clones from activated but not numerically expanded B-cell clones. The present data suggest that B-cell clonal expansion is a common and characteristic feature of rheumatoid arthritis and that it occurs with increasing frequency from the blood to the synovial compartments, resulting in a narrowing of the clonal repertoire at the synovial level. These clonal expansions can involve resting, apparently memory B cells, as well as activated B cells. Furthermore, some of these individual expansions can persist over extended periods of time. These findings support the hypothesis that a chronic ongoing (auto)immune reaction is operative in rheumatoid arthritis and that this reaction, at least at the B-cell level, may be unique to each individual joint. A determination of the targets of these autoimmune reactions may provide valuable clues to help understand the immunopathogenesis of this disease. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Government Data Source",
"mediaType": "text/html",
"description": "Visit the original government dataset for complete information, documentation, and data access.",
"downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17803/"
}
]
|
| identifier | https://healthdata.gov/api/views/cmd3-k482 |
| issued | 2025-07-13 |
| keyword |
[
"b-cell-clones",
"immunoglobulin-vh",
"nih",
"rheumatoid-arthritis",
"synovial-fluid"
]
|
| landingPage | https://healthdata.gov/d/cmd3-k482 |
| modified | 2025-09-06 |
| programCode |
[
"009:033"
]
|
| publisher |
{
"name": "National Institutes of Health",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Clonal expansion is a characteristic feature of the B-cell repertoire of patients with rheumatoid arthritis |